Zylox-Tonbridge Medical Technology Co., Ltd.
Research Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) on Bullrun: market cap HKD 6.63B, P/E 18.8, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2190.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyHKD
- Market capHKD 6.63B
- P/E18.8
- Dividend yield1.3%
- Financial periodFY2025
Valuation Snapshot
latest market cap is HKD 6.63B; P/E is 18.8; dividend yield is 1.3%.
Peer valuation comparison
Latest P/E is 18.79x versus a Healthcare sector median of 21.74x (13.6% below).
Latest dividend yield is 1.25% versus a Healthcare sector median of 2.4% (47.9% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | 0.76 | n/a | n/a | n/a |
| FY2024 | CNY 782.48M | CNY 100.26M | -CNY 17.26M | 71.6% | 0.31 | CNY 418.11M | CNY 90.91M | CNY 3.10B |
| FY2023 | CNY 527.75M | -CNY 78.73M | -CNY 92.48M | 72.9% | -0.24 | CNY 1.09B | CNY 55.88M | CNY 3.05B |
| FY2022 | CNY 334.09M | -CNY 113.56M | -CNY 236.60M | 75.6% | -0.34 | CNY 1.21B | CNY 14.00M | CNY 3.09B |
| FY2021 | CNY 177.91M | -CNY 199.69M | -CNY 205.80M | 74.1% | n/a | CNY 1.42B | CNY 9.41M | CNY 3.14B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 6.63B | 18.8 | 1.3% | 0.25 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.25 HKD, yield 1.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.11 CNY |
About Zylox-Tonbridge Medical Technology Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Zylox-Tonbridge Medical Technology Co., Ltd.'s market cap?
Zylox-Tonbridge Medical Technology Co., Ltd.'s market capitalization is HKD 6.63B.
What is Zylox-Tonbridge Medical Technology Co., Ltd.'s P/E ratio?
Zylox-Tonbridge Medical Technology Co., Ltd.'s price-to-earnings (P/E) ratio is 18.8.
Does Zylox-Tonbridge Medical Technology Co., Ltd. pay a dividend?
Zylox-Tonbridge Medical Technology Co., Ltd. has a dividend yield of 1.3%.
What does Zylox-Tonbridge Medical Technology Co., Ltd. do?
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices.